Disrupting a delicate balance: environmental effects on the thyroid. by Brown, Valerie J
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ublic and scientific un-
ease about possible dis-
ruption of hormones by
man-made substances in the
environment has gathered
steam steadily over the last
decade, propelled significant-
ly by two events of 1996: the publication of
Our Stolen Future, by Theo Colborn,
Dianne Dumanoski, and John Peterson
Myers, and the passage by Congress of the
Food Quality Protection Act and amend-
ments to the Safe Drinking Water Act,
directing the U.S. Environmental Protect-
ion Agency (EPA) to determine whether
and to what extent industrial chemicals dis-
rupt reproductive and thyroid hormones. 
In response to its congressional mandate,
the EPA formed the Endocrine Disruptor
Screening and Testing Advisory Committee
(EDSTAC). In its 1998 final report,
EDSTAC recommended that the EPA
address the effects of pesti-
cides, commercial chemicals,
and other environmental con-
taminants on the endocrine
system, which comprises the
body’s hormones and glands—
the pituitary gland, the adre-
nal gland, the ovaries, the testes, the
pancreas, the hypothalamus, the para-
thyroid gland, and the thyroid gland. 
Because the thyroid affects the adult
body’s major systems, and because it is cru-
cial to fetal development, its disruption by
exogenous chemicals is of intense interest.
Moreover, the thyroid, along with breast
tissue and bone marrow, is especially vul-
nerable to ionizing radiation. Taken
together, these aspects of the thyroid make
understanding environmental influences
on it a fascinating puzzle requiring a mul-
tidisciplinary meld of endocrinology, toxi-
cology, and nuclear medicine to untangle.
Environmental Effects on the Thyroid
Delicate Balance
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The butterfly-shaped thyroid gland, sitting
at the base of the neck just below the larynx,
influences basic metabolism, heart rate,
blood pressure, and body temperature,
among other functions. A variety of disor-
ders can plague it, including autoimmune
disorders, benign and malignant tumors,
and goiter (an enlargement of the thyroid
that may be caused by either over- or under-
production of thyroid hormone). About 13
million Americans have thyroid disorders,
of which nearly 11 million are women and
more than half are undiagnosed, according
to the Thyroid Foundation of America.
Iodine is required to make the thyroid’s
two principal products—thyroxine (T4)
and triiodothyronine (T3), generally known
collectively as “thyroid hormone.” The
World Health Organization (WHO) esti-
mates that 740 million people worldwide
suffer from iodine deficiency—the most
common cause of preventable thyroid dis-
ease and mental retardation in the world—
and only about 57% of people in the devel-
oping world consume iodized salt, the pri-
mary means of correcting iodine deficiency.
Iodine deficiency is common in inland
areas of the world where people do not have
access to iodine-rich foods such as ocean
fish, kelp, and sea salt, or where they con-
sume foods that interfere with the body’s
uptake of iodine.  
Iodine deficiency results in hypothy-
roidism, which leads to weight gain,
fatigue, dry skin, mood swings, and goiter,
among other symptoms. Excess hormone
production, or hyperthyroidism, can cause
anxiety, heart palpitations, insomnia, hair
loss, and weight loss, as well as goiter.
The thyroid is elegantly self-regulating,
enlisting the support of the hypothalamus
and the pituitary gland to maintain a steady
state of hormone availability to the body.
The hypothalamus secretes thyrotropin-
releasing hormone (TRH), which tells the
pituitary to make thyroid-stimulating hor-
mone (TSH). TSH tells the thyroid gland
itself to capture iodine from the blood to
synthesize, store, and release T4. Once T4
has reached an adequate circulating level,
the hypothalamus and pituitary reduce
their output of TRH and TSH until the T4
level again drops. T4 circulates in the blood
both freely and bound to carrier proteins.
When T4 reaches target cells, it is converted
to T3, which is the biologically active form.
(T3 also can be released by the thyroid and
can bind to carrier proteins.) 
A Difficult Subject
The study of the thyroid and its products
presents special challenges to researchers.
Thyroid hormones differ markedly from
reproductive hormones in several respects,
and these differences have made it difficult
to transfer the reproductive hormone
model of chemical endocrine disruption to
the thyroid system. For one thing, estrogens
and androgens are released into the body in
what endocrinologist R. Thomas Zoeller of
the University of Massachusetts Amherst,
who was a member of EDSTAC, calls a
“regulatory pulse.” In contrast, thyroid
product levels “stay pretty much the same
all the time,” and if disturbed will attempt
to return to normal levels. Further, the thy-
roid system affects bodily processes more
globally and more subtly than reproductive
hormones. Thyroid products are “necessary
but not sufficient” to affect physiological
processes, says Zoeller; they are likely to
work in concert with other hormones or
vitamins rather than independently. 
Whereas much of the early endocrine
disruption research started with the effects of
chemicals on nuclear receptors, research into
thyroid disruption initially concentrated on
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An elegant system. The thyroid regulates its hormone output with the aid of the hypothalamus
and the pituitary gland. The hypothalamus secretes thyrotropin-releasing hormone (TRH), trigger-
ing the pituitary to make thyroid-stimulating hormone (TSH). TSH tells the thyroid to capture
iodine from the blood to synthesize, store, and release thyroxine (T4). When T4 reaches target cells,
it is converted to triiodothyronine (T3). The hypothalamus and pituitary reduce their output of TRH
and TSH once T4 reaches an adequate circulating level, then resume output when the T4 level
again drops. 
Hypothalamus
Pituitary Gland
TSH
T3&T 4
Thyroid Gland
TRH
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trying to determine whether chemicals
affect circulating levels of TSH and T4. But
measuring TSH and T4  is a relatively
uncertain assay for detecting the effects of
low-level or chronic chemical or radiation
exposure.  Assays for serum hormones
including T3, T4, and TSH are fairly sophis-
ticated, says Zoeller, “but measuring hor-
mone levels as an assay of thyroid disruption
does not tell us whether there are adverse
effects of this disruption.”
For example, he explains, scientists are
finding that very subtle reductions in circu-
lating T4—reductions so subtle that they
can’t be measured directly but can only be
deduced from a small increase in TSH—
can cause a change in specific developmen-
tal processes in the brain that are controlled
by thyroid hormone. Thus, he says, the typ-
ical interpretation of this observation
would be that the increase in TSH was
compensatory because there were no end
points incorporated into the experimental
design to track the effects of these changes.
This uncertainty has made it more difficult
for researchers to identify possible changes
in thyroid function and metabolism that
may not be reflected in circulating hor-
mone levels. 
With regard to reproductive hor-
mones, “It’s [relatively] easy to pick out
measurements that will provide some
degree of specificity of effect—if you see
the effect, you can be reasonably sure that
the compound was an estrogen or andro-
gen,” says developmental toxicologist
George Daston, a research fellow at
Procter & Gamble in Cincinnati who
served on EDSTAC. “With the thyroid,
we’re having a lot of difficulty pinning
down that degree of specificity.” For exam-
ple, the markers of congenital hypothy-
roidism, such as small stature, low birth
weight, and vision and motor problems,
can be caused by factors other than devel-
opmental thyroid disruption. 
Thyroid and Brain Development
Although it is important to understand how
environmental exposures may affect adults,
effects in adults may be less significant as the
thyroid’s self-correcting feedback system
helps the adult body right itself, and if this
fails, hormone supplementation usually
reestablishes balance. However, the develop-
ing fetus depends upon maternal thyroid
hormones until around the beginning of the
second trimester, and at no time is thyroid
hormone more crucial than during brain
development. Thus, it is in fetal and child-
hood development that environmental fac-
tors may have their greatest impact.
Some neurodevelopmental problems,
such as extreme mental retardation and
deaf-mutism, can be prevented or at least
mitigated with postnatal hormone treat-
ment. But even with treatment, children of
hypothyroidal mothers have a higher-than-
normal incidence of difficulties with spa-
tial, perception, memory, language, and
other skills. In a review of thyroid and brain
development in the June 1994 issue of
EHP Supplements, Susan Porterfield, an
endocrinologist at the Medical College of
Georgia in Augusta, suggested that these
problems probably stem more from the
fetus’s lack of available thyroid hormone
than from inadequate hormone replace-
ment for the newborn. Therefore, because
most developmental deficits are irreversible,
mechanisms by which environmental expo-
sures disrupt the thyroid’s role in develop-
ment are currently the focus of much
research interest.
Basic fetal brain development is under
way in humans within the first few weeks of
gestation. Spinal cord and hindbrain com-
ponents grow at this point, and cerebral
cortex structures begin to take shape about
halfway through gestation. Neural synapses
begin forming as early as the second month
of gestation, peaking in the child’s first year
of life, and many parts of the brain contin-
ue to develop postnatally and even into
adulthood. Thyroid hormone is essential
for neuron formation, synapse develop-
ment, formation of myelin (the sheath sur-
rounding neurons that enhances nerve
impulse transmission), and migration of
neurons to their proper places in the brain.
Although the fetal thyroid begins to
grow around the end of the first trimester,
it does not begin producing its own prod-
ucts until the second trimester, and the
hypothalamic–pituitary–thyroid axis is not
mature until the last trimester. Thus,
maternal thyroid hormone must be contin-
uously available until birth because crucial
brain development take place before the
fetus’s thyroid system is up and running. 
Extreme maternal hypothyroidism leads
to neurological cretinism, which can
include spastic diplegia (a form of cerebral
palsy), deafness, and severe mental retarda-
tion. On the other hand, maternal hyper-
thyroidism can result in low birth weight,
prematurity, and, in the case of maternal
Graves disease (an autoimmune disorder
marked by hyperthyroidism), an increased
incidence of congenital malformations.
Even small changes in thyroid hormone
availability during critical periods of brain
development can have troubling results.
Children born to mothers with hypothy-
roxinemia, or low circulating levels of T4,
may have difficulty with motor coordina-
tion, balance, and other psychomotor prob-
lems. Some research also suggests that
attention deficit/hyperactivity disorder may
result in children of hypothyroidal moth-
ers, and studies summarized by Gabriella
Morreale de Escobar and colleagues from
Madrid’s Alberto Sols Biomedical Research
Institute in the November 2000 issue of the
Journal of Clinical Endocrinology &
Metabolism demonstrate 5- to 6-point IQ
deficits in children of mothers with
hypothyroxinemia. 
For these reasons, elucidating the effects
of low-level exposures to environmental
toxicants during gestation is vital, says Ted
Schettler, science director for the Science
and Environmental Health Network, a
nongovernmental organization. Schettler,
who served on EDSTAC, points out that
even small changes in IQ resulting from
fetal thyroid hormone disruption can have
important ramifications, depending on
where the person falls on the IQ spectrum.
A drop in IQ from 75 to 70, for example,
can make the difference between institu-
tional care and independent living, which
in turn translates to significant economic
effects on society. 
Answering the questions regarding envi-
ronmental factors in fetal brain develop-
ment involving the thyroid would be easier
if there were only one or two mechanisms
by which thyroid function can be disrupt-
ed. But in a comprehensive September
1998 review article in Thyroid, Françoise
Brucker-Davis, now on the faculty at the
Centre Hospitalier Universitaire in Nice,
France, identified nearly 90 separate com-
pounds having thyroid-disrupting proper-
ties. And in the June 2002 issue of EHP
Supplements, Kembra L. Howdeshell, now a
postdoctoral fellow working at the Univ-
ersity of Michigan in Ann Arbor, noted 12
separate types of interference in thyroid
mechanisms. This recent work builds on
earlier research and analysis by scientists
such as Charles Capen, a professor of vet-
erinary biosciences at The Ohio State
University in Columbus, and R. Michael
McClain, formerly a research leader at
Hoffman-La Roche, who in the 1980s first
espoused the idea that there are multiple
mechanisms by which environmental
agents alter thyroid function.
The primary types of interference in
thyroid mechanisms are inhibition of
iodine uptake by the thyroid gland, bind-
ing of exogenous chemicals to the serum
proteins normally intended to transport
T4 to target cells, inhibition of hormone
synthesis in the gland, and breakdown
and elimination of thyroid products by
the liver. There is also the possibility that
some chemicals interfere with cellular uti-
lization of thyroid hormone by attaching
to the receptors and acting as agonists or
Focus | Disrupting a Delicate Balanceantagonists of the hormone action itself,
or by interacting with receptor cofactors.
Research has not yet clearly established
these processes, however.
Chemical Culprits?
In  her 1998 review of both animal and
human studies, Brucker-Davis found that,
in general, there was abundant evidence
from wildlife and laboratory animal
research that environmental chemicals do
disrupt thyroid function. Yet she could
come to few firm conclusions with respect
to humans, partly because many human
studies indicate only mild effects, and, she
wrote, because “the presence of multiple
contaminants makes it difficult to sort out
the respective role of individual chemicals.”
Brucker-Davis argued in her review
that the strongest evidence of thyroid dis-
ruption by chemicals is that iodine defi-
ciency occurs in iodine-sufficient areas,
implying that some unidentified influence
interrupts what would otherwise be a fair-
ly straightforward process. As a research
agenda, she suggested concentrating on the
chemicals having structures similar to thy-
roid hormone and those that alter liver
metabolism of thyroid hormone. The for-
mer are candidates for action at cell recep-
tor sites and binding to carrier proteins,
and the latter could trigger the TSH feed-
back mechanism.
Many of the same chemicals thought to
damage the reproductive hormone system
are also suspected or known to affect the
thyroid. These include polychlorinated
biphenyls (PCBs) and their relatives the
polybrominated diphenyl ethers (PBDEs),
ethylenebisdithiocarbamates (EBDCs),
dioxins, and perchlorate. Each family of
compounds may contain several different
congeners that have similar but not identi-
cal actions—or very dissimilar actions, or
no actions at all—further complicating the
puzzle.
PCBs, once used widely in electrical
equipment, were banned in the United
States in 1979 because they were associat-
ed with cognitive impairments, immune
disorders, and cancer in humans. PBDEs
have come into widespread use over the
last 20 years as flame retardants in prod-
ucts such as carpet and computer plastics.
Both groups are persistent in the environ-
ment and bioaccumulate up the food web.
Dioxins—by-products of organochlorine
synthesis, waste combustion, and paper
production—are structurally similar to
PCBs and PBDEs. They, too, are persist-
ent and are often mixed with PCBs in the
environment. 
PCBs probably affect thyroid function
by displacing T4 from serum-binding pro-
teins in blood and by increasing liver metab-
olism of thyroid hormones. A paradox of
PCB effects, says Zoeller, is that they reduce
circulating T4 without increasing TSH.
PBDEs and dioxins have similar effects. 
EBDCs are potent fungicides. They are
used on many plants, including root and
leafy vegetables, fruits, and cereals, both in
the field and after harvest. They have been
known since the 1960s to cause goiter and
to inhibit iodine uptake. The body breaks
them down to ethylenethiourea, which has
been identified by the EPA as a thyroid car-
cinogen in rats and mice and a probable
human carcinogen. EBDCs can lower levels
of thyroid hormone in rats at low doses,
and may affect TSH. Ethylenethiourea also
inhibits thyroid peroxidase, an enzyme nec-
essary for synthesis of T3 and T4. 
Perchlorate, used as an oxygen source in
missile and rocket fuel, is common in
drinking water in the southwestern United
States. It inhibits iodine uptake by the thy-
roid, which can result in hypothyroidism
and thyroid tumors. The EPA is in the
process of setting a reference dose for per-
chlorate exposure in humans. 
But these toxicants aren’t the only
chemicals that affect the thyroid. Fluoride,
an element common in U.S. drinking
water either naturally or added as a dental
caries preventive, also suppresses thyroid
hormone, although the mechanism is not
understood, according to Paul Connett, a
professor of chemistry at St. Lawrence
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Cancer cloud? Fallout from detonations at the Nevada Proving Grounds (above) and other sites
has been the subject of intense research on ionizing radiation, the only known cause of human
thyroid cancer.Environmental Health Perspectives • VOLUME 111 | NUMBER 12 | September 2003  A 647
University in Canton, New York, and an
activist opposing the addition of fluoride
to water. But the U.S. Food and Drug
Administration emphasizes that fluoride
concentrations in drinking water are safe,
and most thyroid researchers believe
many other chemicals pose a greater
threat.
Another culprit, cyanide, occurs natu-
rally in more than 1,000 plants, including
cassava, sorghum, and bamboo, all impor-
tant food sources in many parts of the
developing world. At chronic subacute
levels of exposure, cyanide can produce
goiter and hypothyroidism. According to
the Cassava Cyanide Diseases Network, a
collaborative group of government offi-
cials and academics in Mozambique and
Australia, cyanide contributes to goiter
when the diet is already iodine-deficient.
Traditional methods of processing cassava
effectively neutralize cyanide’s health
effects, but according to WHO regional
surveys of iodine deficiency status in
Africa, ongoing wars, famines, and result-
ing mass migrations of African peoples
dependent on cassava have interrupted
such processing methods in many places,
increasing the exposure of these already-
stressed populations.
Soy isoflavones, touted by many as a
benign substitute for endogenous estrogens
for postmenopausal women, can be goitro-
genic, although the amounts usually con-
sumed by adults are insufficient to have that
effect. Findings by toxicologist Daniel
Doerge of the National Center for Tox-
icological Research and colleague Daniel M.
Sheehan, reported in the June 2002 issue of
EHP Supplements, suggest that soy iso-
flavones’ ability to disrupt the thyroid
depends on other factors such as iodine
deficiency, other dietary goitrogens, and
underlying thyroid dysfunction. Doergeem-
phasized the need for further research into
the safety of soy isoflavones.
Many other foods
contain thyroid-dis-
rupting compounds,
such as millet (con-
taining epigenin and
luteolin) and the cab-
bage family (contain-
ing goitrin). In parts
of Africa where goiter
is endemic, such as
Sudan and the Republic of Guinea, it prob-
ably results from the combination of under-
lying iodine deficiency and large amounts of
millet in the diet.
Radiation: Out, In, High, Low?
The thyroid can be affected by ionizing
radiation through the skin by gamma radi-
ation, including X rays; by fission products,
such as cesium; or by ingestion or inhala-
tion of iodine-131 (131I), an isotope present
in nuclear fission products. 131I emits most-
ly beta radiation, which penetrates surfaces
more shallowly than gamma radiation. It
has a half-life of only about eight days, but
in fallout form it can be inhaled directly or
taken up by plants eaten by cows and goats,
in whose milk it is then expressed. The thy-
roid cannot distinguish 131I from the non-
radioactive form. 
Ionizing radiation is at present the only
known cause of human thyroid cancer.
Thyroid tumors, or nodules, rarely result in
detectable disruption of thyroid function.
About 1% of these tumors are malignant
and are treated with surgery, radiation, or
both.
Most radiation research has focused on
exposures from nuclear bomb tests,
wartime bomb drops, and nuclear power
plant accidents. Bomb drops and tests
occurred from 1945 until aboveground
testing was phased out in 1963. Possibly the
most famous nuclear events were the
Hiroshima and Nagasaki bombings in
1945. Other significant exposures occurred
as the result of weapons production and
testing in the Marshall Islands from 1946
to 1958, in the American West north and
east of the Nevada bomb tests—principally
in Utah and Idaho—from 1951 to 1963,
and near the Hanford Nuclear Site in east-
ern Washington State from 1944 to 1957
(lesser releases continued at Hanford until
1972). The 1986 explosion and fire at the
Chernobyl nuclear power plant exposed
some 5 million people in Belarus, Ukraine,
and Russia to radiation.
Of  the fallout victims studied, the
Japanese victims received high doses of
mixed external radiation in a very short
time, the Marshall Islanders and Utah resi-
dents received primarily 131I exposure peri-
odically over about 12 years, and Hanford
downwinders probably received relatively
lower doses, primarily of 131I, from multi-
ple releases over a slightly longer period.
The Chernobyl accident produced an
acute, rapid exposure, mostly to 131I but
also to a mixture of other fission products.
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Far-flung effects. The 1986 explosion and fire at the Chernobyl nuclear power plant exposed
some 5 million people in Belarus, Ukraine, and Russia to radioactive fallout. Children are the
accident’s youngest victims, suffering high rates of thyroid cancers. Thus, in none of these events was there a
clear-cut relationship among radiation
type, duration of exposure, and internal
versus external exposure.
High doses of external gamma radiation
can damage thyroid gland tissue and lead to
hypothyroidism as well as benign or malig-
nant nodules, but the effects of low doses,
especially of beta radiation such as 131I, are
less certain. There was some increase in the
incidence of both benign and malignant
nodules among weapons-exposed popula-
tions, and Chernobyl victims, primarily
children, suffered a striking spike in thyroid
cancer incidence. According to the United
Nations Scientific Committee on the
Effects of Atomic Radiation’s 2000 report,
Sources and Effects of Ionizing Radiation,
1,791 children under 18 at the time of the
accident were diagnosed with thyroid can-
cer between 1990 and 1998 in Belarus,
Russia, and Ukraine, representing a four-
fold increase in incidence. In Belarus, the
incidence in children under 15 at diagnosis
jumped from 0.2 per 100,000 to 5.6 per
100,000 in 1995, then tapered to 3.9 per
100,000 by 1998. Because some Chernobyl
victims were iodine-deficient, their risk of
cancer may have been magnified.
Although Chernobyl provided strong
evidence that high 131I exposure increases
cancer risk, it did not answer the question
of whether low chronic doses do so, but
research on Hanford downwinders seems to
indicate low risk from low chronic doses.
Yet, “nothing’s crystal-clear regarding radia-
tion effects,” says Scott Davis, chairman of
the Department of Epidemiology at the
University of Washington School of Public
Health and Community Medicine in
Seattle. 
Davis directed the Hanford Thyroid
Disease Study (HTDS), which was con-
ducted in response to a 1988 congressional
mandate to the U.S. Centers for Disease
Control and Prevention (CDC). The study
asked whether exposure to 131I from
Hanford resulted in increased incidence of
thyroid disease among 3,441 subjects iden-
tified as having lived in the highest-expo-
sure areas during the relevant period. The
study found that the risk of thyroid disease
did not vary with radiation dose and that
Hanford downwinders were at no higher
risk of thyroid disease than the general pop-
ulation. The preliminary HTDS results
were  released by the CDC in its 1999
Hanford Thyroid Disease Study Draft Final
Report to a chorus of criticism from down-
winders, antinuclear activists, and some sci-
entists. The final CDC report was issued in
2002, but the HTDS results have not yet
been published in a peer-reviewed journal;
papers based on HTDS data are currently
under review by several journals, according
to Davis. 
The 2000 National Academy of
Sciences  Review of the Hanford Thyroid
Disease Study Draft Final Report supported
the study’s methodology but noted the
report’s reliance on highly uncertain dose
amounts. In addition, Keith Baverstock, a
prominent Chernobyl researcher with the
WHO European Center for Environment
and Health in Bonn, Germany, noted in a
comment posted at the HTDS website
(http://www.cdc.gov/nceh/radiation/
hanford/htdsweb/index.htm) that the
results could indicate an excess of thyroid
cancer cases, and that “there are certainly
more cases detected than would be expect-
ed on the basis of the national rates for
invasive thyroid cancer.” Follow-up
research on the Hanford and Chernobyl
victims is ongoing.
Next Steps
At  this point in the understanding of
environmental effects on the thyroid,
there are far more questions than answers,
but whether the toxicant under consider-
ation is chemical or radioactive, most of
the questions have to do with the effects
of low-level exposures rather than acute
ones. A further critical issue is whether
combinations of toxicants have synergistic
effects or sometimes even cancel each
other out. Because the effects of low-level
exposure may be subtle, Schettler thinks
the precautionary principle should be
implemented long before unambiguous
results accumulate from laborious labora-
tory and epidemiologic studies. 
As researchers implement the EPA
mandate to study endocrine disruption,
they must tackle some difficult procedur-
al issues. For example, the rat thyroid sys-
tem has been well characterized, but
because rats and humans may metabolize
certain toxicants differently (and thus, for
example, rats may receive noncomparable
doses of hydrophobic toxicants such as
PCBs via breast milk), it is not certain
how confidently researchers can extrapo-
late rat results to humans. 
Kevin Crofton, a behavioral neurotox-
icologist at the EPA National Health and
Environmental Effects Research Lab-
oratory in Research Triangle Park, North
Carolina, points to other problems: “One
of the big issues is potential difference in
susceptibility of the developing rat brain
versus the developing human brain,” he
says. “For example, epidemiologic studies
have shown that a twenty-five percent
decrease in maternal T4 during the first
trimester results in decreased IQ in
children, [but] there are no rat models
that demonstrate this level of sensitivity to
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Xenopus and us. Researchers are working to develop animal models of gene regulation by
thyroid hormone including one that studies the metamorphosis from tadpole (above) to frog
of the African clawed frog (Xenopus laevis).
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T4 decreases. . . . Alternatively, the meas-
ures of neurological development in the
rat may be crude compared to IQ testing
in children.”
Many features of brain development
are strongly conserved in vertebrates,
however. Howdeshell is working to devel-
op a model of the African clawed frog,
Xenopus laevis, to shed light on gene reg-
ulation by thyroid hormone in human
processes including brain development.
Xenopus provides a good model for thy-
roid hormone effects because the meta-
morphosis from tadpole to frog is heavily
mediated by thyroid hormone. “While
Xenopus studies cannot be directly extrap-
olated to human development,” says
Howdeshell, “the thyroid hormone sys-
tem is conserved across all vertebrates,
including rats and humans, and Xenopus
undergo thyroid hormone–directed brain
maturation similar to the brain develop-
ment of more complex vertebrates.”
The lack of certainty regarding circu-
lating hormone levels as a measure of tox-
icant effects is also vexing, and researchers
are busy devising better assays and end
points. Crofton has identified one such
end point that he thinks may be a reliable
indicator. In research currently under
review, he has correlated postnatal T4 con-
centrations with hearing loss in rats.
These data demonstrate that, at a mini-
mum, a 50% decrease of thyroid hormone
in developing rats is needed to adversely
impact hearing function.
A further issue is that endocrine dis-
ruption research involves to some extent a
culture clash between toxicologists and
endocrinologists; the methods and typical
questions of interest peculiar to each
must be harmonized with the other. For
example, toxicologists tend to focus on
dose–response determinations, whereas
endocrinologists historically haven’t con-
sidered dose response with respect to hor-
mones at all, says Zoeller. 
To  help harmonize the disciplines
and develop a joint research agenda, the
NIEHS sponsored two meetings last year:
Thyroid Hormone and Brain Development:
Translating Molecular Mechanisms to
Population Risk, an international confer-
ence that took place 23–25 September 2002
in Research Triangle Park, and Thyroid
Toxicants: Assessing Reproductive Health
Effects, a workshop held 28–29 April 2003
in Alexandria, Virginia. Many of the most
pressing questions were discussed at both,
and researchers were encouraged by the
interdisciplinary scope of the research pro-
gram being implemented in response to the
EPA’s mandate. 
The thyroid system is so complex that
understanding its normal function is diffi-
cult enough, but deciphering environmental
disruptions to it is staggeringly convoluted.
Yet, the more research reveals, the more
pressing the questions become. The thyroid
affects nearly every bodily system, and its
role in fetal development makes protection
of healthy thyroid function imperative. The
increasing body of research indicating subtle
and possibly additive or synergistic effects of
environmental contaminants only adds
salience to the issue.
Valerie Brown
Focus | Disrupting a Delicate Balance